News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sirtris Pharmaceuticals (SIRT) to Present at First Annual Boston Biotech R&D Conference


10/17/2008 9:22:44 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris, a GSK company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, today announced that it will provide an update on the Company’s clinical and preclinical progress at the 2008 Boston Biotech R&D Conference on Wednesday, October 22, 2008 at Harvard Medical School.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES